Why the study?
Does Roux-en-Y gastric bypass surgery improve cardiometabolic disease risk factors in women with polycystic ovarian syndrome?
Population
389 women with polycystic ovarian syndrome who underwent Roux-en-Y gastric bypass surgery from 2001-2009 in…
Design
Cohort
Follow-up
1 year
Authors
Loading...
RYGB was associated with 1-year cardiometabolic improvements in PCOS across ethnicities; hypothesis-generating and should not yet alter practice.
Does Roux-en-Y gastric bypass surgery improve cardiometabolic disease risk factors in women with polycystic ovarian syndrome?
Roux-en-Y gastric bypass surgery significantly improves BMI and various cardiometabolic risk factors at 1 year in women with PCOS, with some variations in specific metabolic improvements across ethnicities.
Carley Gomez-Meade (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: